Negotiated reimbursement price applicable 12 months after launch
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
The IQWiG has just published draft version 6.1 of its “General methods”. The General Methods describe the work procedures of the IQWiG,
This new DMP for obesity should consider and combine various therapeutic approaches to offer the best possible care, treat patients with obesity
We do often talk about pharmaceutical companies aiming to achieve “reimbursement” for the products, but what does that actually mean in real
Early benefit assessments are completed within 12 months, while method assessments used to take around 3 years. In 2020, the G-BA introduced